Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for Fennec Pharmaceuticals in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$9.69.
Current Consensus is
The current consensus among 2 polled investment analysts is to buy stock in Fennec Pharmaceuticals. This Buy consensus rating has held steady for over two years.